Actavis will acquire Forest Laboratories for approximately $25 billion in cash and equity, a premium of 25% above Forest’s stock price. The combined company is expected to have revenues in excess of $15 billion in 2015, and Actavis chairman and chief executive officer Paul Bisaro anticipates annual R&D spend will exceed $1 billion. Brent Saunders, chief executive officer and president of Forest, remarked, “Forest is a great fit with Actavis due to our strong legacy in branded sp...